Total Funding
56
46
Total FundingGrant raised
Growth Score
-4 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
90401
Medtech company commercializing a revolutionary cardiac assist device: biventricular and without blood-contact
- Andreas Maier: CTO and CPO
- Stephen Wildhirt: Co-Founder and CEO
About the Company
AdjuCor is a high-tech medical device company that owns and is responsible for development, production, marketing and selling of a revolutionary technology for the treatment of advance heart failure patients. Its flagship product is called reBEAT. The market introduction of reBEAT will be the world’s first commercially available, minimal invasive
application of mechanical circulatory support for the failing heart that not only provides uni- or biventricular support, but also completely avoids contact with blood. This unique feature set will allow for the transformation of standard-of-care treatment in advanced heart failure setting, as well as greatly expand treatment to previously unreached patients.
